Logo image
Stereotactic radiosurgery for unruptured versus ruptured pediatric brain arteriovenous malformations
Journal article   Peer reviewed

Stereotactic radiosurgery for unruptured versus ruptured pediatric brain arteriovenous malformations

Ching-Jen Chen, Cheng-Chia Lee, Dale Ding, Shih-Wei Tzeng, Kathryn N. Kearns, Hideyuki Kano, Ahmet Atik, Natasha Ironside, Krishna Joshi, Paul P. Huang, …
Stroke, Vol.50(10)
2019

Abstract

Adolescent Arteriovenous Fistula Cerebral Hemorrhage Child Female Humans Intracranial Arteriovenous Malformations Male Radiation Injuries Radiosurgery Retrospective Studies Treatment Outcome adolescent Article artificial embolization brain arteriovenous malformation carcinogenesis child cohort analysis comparative study female follow up human major clinical study male postoperative complication postoperative hemorrhage priority journal retrospective study school child stereotactic radiosurgery adverse event arteriovenous fistula brain arteriovenous malformation brain hemorrhage complication procedures radiation injury radiosurgery treatment outcome
Background and Purpose—The effects of prior hemorrhage on stereotactic radiosurgery (SRS) outcomes for pediatric arteriovenous malformations (AVMs) are not well defined. The aim of this multicenter, retrospective cohort study is to compare the SRS outcomes for unruptured versus ruptured pediatric AVMs. Methods—The International Radiosurgery Research Foundation pediatric AVM database from 1987 to 2018 was reviewed retrospectively. Favorable outcome was defined as AVM obliteration, no post-SRS hemorrhage, and no permanently symptomatic radiation-induced changes. Associations between prior hemorrhage and outcomes were adjusted for baseline differences, inverse probability weights, and competing risks. Results—The study cohort comprised 153 unruptured and 386 ruptured AVMs. Favorable outcome was achieved in 48.4% and 60.4% of unruptured and ruptured AVMs, respectively (adjusted odds ratio, 1.353; P=0.190). Cumulative AVM obliteration probabilities were 51.2%, 59.4%, 64.2%, and 70.0% for unruptured and 61.0%, 69.3%, 74.0%, and 79.3% for ruptured AVMs at 4, 6, 8, and 10 years, respectively (subhazard ratio, 1.311; P=0.020). Cumulative post-SRS hemorrhage probabilities were 4.5%, 5.6%, 5.6%, and 9.8% for unruptured and 4.7%, 6.1%, 6.1%, and 10.6% for ruptured AVMs at 4, 6, 8, and 10 years, respectively (subhazard ratio, 1.086; P=0.825). Probabilities of AVM obliteration (adjusted subhazard ratio, 0.968; P=0.850) and post-SRS hemorrhage (adjusted subhazard ratio, 1.663; P=0.251) were comparable between the 2 cohorts after inverse probability weight adjustments. Symptomatic (15.8% versus 8.1%; adjusted odds ratio, 0.400; P=0.008) and permanent (9.2% versus 5.0%; adjusted odds ratio, 0.441; P=0.045) radiation-induced change were more common in unruptured AVMs. Conclusions—The overall outcomes after SRS for unruptured versus ruptured pediatric AVMs are comparable. However, symptomatic and permanent radiation-induced change occur more frequently in pediatric patients with unruptured AVMs. © 2019 American Heart Association, Inc.

Details

Logo image